A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics After Administration of SID1903 (Fixed-dose Combination of Dapagliflozin and Sitagliptin) or Loose Combination in Healthy Adult Volunteers
Latest Information Update: 28 Oct 2022
At a glance
- Drugs Dapagliflozin/sitagliptin (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors SK Chemicals
Most Recent Events
- 28 Oct 2022 New trial record